• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    DuPont de Nemours Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    5/28/25 4:58:12 PM ET
    $DD
    Major Chemicals
    Industrials
    Get the next $DD alert in real time by email
    dd-20250522
    0001666700false00016667002025-05-222025-05-22

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 8-K


    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 28, 2025 (May 22, 2025)

    DuPont de Nemours, Inc.
    (Exact name of registrant as specified in its charter)
                
    Delaware
    001-38196
    81-1224539
    (State or other jurisdiction of
    incorporation)
    (Commission file number)
    (IRS Employer Identification No.)
    974 Centre Road, Building 730Wilmington, Delaware19805
    (Address of Principal Executive Offices)
    (Zip Code)

    (302) 295-5783
    (Registrant’s Telephone Number, Including Area Code)

    Not applicable
    (Former name or former address, if changed since last report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, par value $0.01 per shareDDNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨




    Section 5 - Corporate Governance and Management
    Item 5.07 Submission of Matters to a Vote of Security Holders.

    On May 22, 2025, DuPont de Nemours, Inc. (the “Company”) held its Annual Meeting of Stockholders. As of the close of business on March 31, 2025, the record date for the Annual Meeting, (the "Record Date"), 418,498,498 shares of the Company’s common stock, par value $0.01 per share, were outstanding and entitled to vote. A total of 339,910,658 shares of common stock were voted in person or by proxy, representing 81.22 percent of the shares entitled to be voted. The following are the final voting results on the matters considered and voted upon at the Annual Meeting, all of which are described in the Company’s 2025 Proxy Statement.

    Agenda Item 1-Election of Directors. The Company’s stockholders elected the following 13 nominees to serve on the Board of Directors of the Company until the next annual meeting of stockholders or until their successors have been duly elected and qualified.
    DirectorForAgainstAbstainBroker Non-Votes
    Amy G. Brady279,921,5891,905,670545,48157,537,918
    Edward D. Breen275,968,6085,853,928550,20457,537,918
    Ruby R. Chandy279,651,2692,177,331544,14057,537,918
    Terrence R. Curtin278,625,9703,132,098614,67257,537,918
    Alexander M. Cutler268,630,46813,170,217572,05557,537,918
    Eleuthère I. du Pont278,656,2463,184,625531,86957,537,918
    Kristina M. Johnson278,771,1643,047,958553,61857,537,918
    Luther C. Kissam, IV278,596,9243,201,664574,15257,537,918
    Lori D. Koch279,787,3352,031,859551,13957,537,918
    James A. Lico279,767,6392,019,558585,54357,537,918
    Frederick M. Lowery273,000,2128,800,362572,16657,537,918
    Kurt B. McMaken277,579,5634,205,106588,07157,537,918
    Steven M. Sterin279,804,3221,943,153625,26557,537,918

    Agenda Item 2-Advisory Resolution to Approve Executive Compensation. The Company’s stockholders approved, by advisory vote, the compensation of its named executive officers.
    ForAgainstAbstainBroker Non-Votes
    257,257,81522,559,0362,555,88957,537,918

    Agenda Item 3-Ratification of the Appointment of the Independent Registered Public Accounting Firm. The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2025.
    ForAgainstAbstainBroker Non-Votes
    336,941,7942,243,977724,887—





    Section 9 - Financial Statements and Exhibits
    Item 9.01 Financial Statements and Exhibits.
    (d)    Exhibits.
    104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.




    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    DUPONT DE NEMOURS, INC.
    Registrant
    Date:May 28, 2025By:/s/ Michael G. Goss
    Name:Michael G. Goss
    Title:Vice President and Controller


    Get the next $DD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DD

    DatePrice TargetRatingAnalyst
    4/15/2025$75.00Underperform → Neutral
    BofA Securities
    4/14/2025$81.00Sector Weight → Overweight
    KeyBanc Capital Markets
    2/13/2025$85.00 → $89.00Underweight → Equal Weight
    Barclays
    1/17/2025$91.00Peer Perform → Outperform
    Wolfe Research
    10/7/2024$88.00 → $84.00Equal Weight → Underweight
    Barclays
    5/28/2024$85.00 → $95.00Neutral → Buy
    Citigroup
    5/24/2024$80.00 → $103.00Equal Weight → Overweight
    Wells Fargo
    5/23/2024$96.00Market Perform → Outperform
    BMO Capital Markets
    More analyst ratings

    $DD
    SEC Filings

    See more
    • SEC Form 11-K filed by DuPont de Nemours Inc.

      11-K - DuPont de Nemours, Inc. (0001666700) (Filer)

      6/13/25 4:27:24 PM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont de Nemours Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

      5/28/25 4:58:12 PM ET
      $DD
      Major Chemicals
      Industrials
    • SEC Form SD filed by DuPont de Nemours Inc.

      SD - DuPont de Nemours, Inc. (0001666700) (Filer)

      5/15/25 11:37:22 AM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Lowery Frederick M. was granted 580 shares, increasing direct ownership by 2% to 32,579 units (SEC Form 4)

      4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

      6/3/25 5:10:02 PM ET
      $DD
      Major Chemicals
      Industrials
    • Director Cutler Alexander M was granted 749 shares, increasing direct ownership by 1% to 72,865 units (SEC Form 4)

      4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

      6/3/25 5:09:34 PM ET
      $DD
      Major Chemicals
      Industrials
    • Director Curtin Terrence R was granted 487 shares, increasing direct ownership by 2% to 30,370 units (SEC Form 4)

      4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

      6/3/25 5:08:54 PM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • DuPont upgraded by BofA Securities with a new price target

      BofA Securities upgraded DuPont from Underperform to Neutral and set a new price target of $75.00

      4/15/25 8:43:17 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont upgraded by KeyBanc Capital Markets with a new price target

      KeyBanc Capital Markets upgraded DuPont from Sector Weight to Overweight and set a new price target of $81.00

      4/14/25 8:04:47 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont upgraded by Barclays with a new price target

      Barclays upgraded DuPont from Underweight to Equal Weight and set a new price target of $89.00 from $85.00 previously

      2/13/25 8:08:02 AM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by DuPont de Nemours Inc.

      SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

      11/12/24 11:54:03 AM ET
      $DD
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by DuPont de Nemours Inc. (Amendment)

      SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

      2/13/24 4:55:53 PM ET
      $DD
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by DuPont de Nemours Inc.

      SC 13G - DuPont de Nemours, Inc. (0001666700) (Subject)

      2/9/24 11:49:03 AM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DuPont Completes Qnity™ Board of Directors

      Mark Blinn announced as director and chairman and Yi Hyon Paik as director WILMINGTON, Del., June 11, 2025  /PRNewswire/ -- DuPont (NYSE:DD) today announced that Mark A. Blinn and Dr. Yi Hyon Paik will become members of the future board of directors (the "Qnity Board") for Qnity Electronics, Inc., the planned, independent Electronics public company created from DuPont's intended spin-off.* Mr. Blinn will become chairman of the Qnity Board effective with the spin-off. Mr. Blinn was chief executive officer, president, and director of Flowserve Corporation until his retirement in

      6/11/25 8:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Innovators in Semiconductor Materials Named 2025 Heroes of Chemistry

      Breakthrough in Semiconductor Lithography Recognized by the American Chemical Society WILMINGTON, Del., June 10, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that 13 of its current and former scientists and engineers have been named 2025 Heroes of Chemistry by the American Chemical Society (ACS) for an innovative program that progressed semiconductor lithography. The award recognizes the collaborative development of embedded barrier layer technology, a transformative advancement in 193 nm immersion lithography that significantly improved chip fabrication processes by

      6/10/25 11:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Expands Healthcare Manufacturing Site in Costa Rica, Adding Sterile Packaging Capacity

      The 16,000-square-foot expansion enhances DuPont's global sterile operations, increases the capacity of the manufacturing site's existing medical tubing operations, and enables Costa Rica's first-ever production of sterile healthcare packaging. WILMINGTON, Del., June 5, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that it has expanded its sterile operations via an addition to its healthcare manufacturing facility in Heredia, Costa Rica, enabling the site to produce sterile packaging for the global medical device industry while also increasing the capacity of the site's existing medical tubing operations.

      6/5/25 9:00:00 AM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    Leadership Updates

    Live Leadership Updates

    See more
    • DuPont Announces Appointment of Kurt McMaken to Board of Directors

      WILMINGTON, Del., Feb. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of Kurt McMaken to its Board of Directors, effective immediately. Mr. McMaken will serve on the Audit committee and Nomination and Governance committee. "We are pleased to welcome Kurt to DuPont's Board of Directors," said DuPont Executive Chairman Ed Breen. "Kurt's global business expertise in the manufacturing sector and extensive background in finance and strategic planning make him well suited to help guide DuPont's growth and value creation strategies. We look forward to his c

      2/21/25 4:15:00 PM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Announces Two Technology Leaders as DuPont Laureates

      Dr. Deyan Wang and Nicholas Sands Recognized for a Career of Innovation and Business Impact; Achieve Highest Technical Level in the Company WILMINGTON, Del., Oct. 10, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced that two of its technology leaders have achieved the professional distinction of DuPont Laureate, the company's most distinguished technical designation. The newly appointed Laureates are Dr. Deyan Wang, DuPont Electronics & Industrial and Nicholas (Nick) Sands of DuPont Water & Protection. "I'm tremendously honored to recognize Deyan and Nick, two of DuPont's

      10/10/24 9:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont to Acquire Donatelle Plastics Incorporated

      Transaction deepens healthcare offerings in medical device solutions WILMINGTON, Del., June 25, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has signed an agreement to acquire Donatelle Plastics Incorporated, a leading medical device contract manufacturer specializing in the design, development and manufacture of medical components and devices. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. "Our healthcare strategy is focused on offering a comprehensive sui

      6/25/24 9:00:00 AM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    Financials

    Live finance-specific insights

    See more
    • DuPont Achieves 100 Percent Renewable Electricity Across its European Union Operations

      Company marks significant progress towards 2050 climate goals WILMINGTON, Del., May 27, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced 100 percent of its grid electricity is from renewable sources across its entire European Union (EU) operations, through the use of Renewable Energy Certificates (RECs). This milestone underscores the company's commitment to achieving its renewable energy goal and acting on climate stewardship as part of its 2030 Sustainability Goals, as well as marking a key step towards DuPont's commitment of net-zero carbon emissions by 2050. "At DuPon

      5/27/25 9:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Reports First Quarter 2025 Results

      Net Sales of $3.1 billion increased 5%; organic sales increased 6% versus year-ago periodGAAP Loss from continuing operations of $(548) million, includes $768 million non-cash goodwill impairment charge related to first quarter segment realignment; operating EBITDA of $788 millionGAAP EPS from continuing operations of $(1.33); adjusted EPS of $1.03Cash provided by operating activities from continuing operations of $382 million; transaction-adjusted free cash flow of $212 millionMaintaining full year 2025 financial guidance; separately providing tariff impact sensitivityWILMINGTON, Del., May 2, 2025 /PRNewswire/ -- DuPont (NYSE:DD) announced its financial results(1) for the first quarter ende

      5/2/25 6:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Announces Regular Quarterly Dividend on Common Stock

      WILMINGTON, Del., April 29, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that its Board of Directors has declared a quarterly dividend of forty-one cents ($0.41) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on June 16, 2025, to holders of record of said stock at the close of business on May 30, 2025. About DuPontDuPont (NYSE:DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers a

      4/29/25 4:30:00 PM ET
      $DD
      Major Chemicals
      Industrials